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ract. Paradoxical deterioration during antituberculosis therapy, defined as the 
or radiological worsening of pre-existing tuberculous lesions or the 
lopment of new lesions in a patien
ostic dilemma. Althou
nse have been described, a systematic analysis of the entity in 
HIV-infected patients is lacking. Reported here are two cases of paradoxical 
ioration in which sequential changes in lymphocyte counts and tuberculin skin 
s are emphasized. In addition, 120 episodes of paradoxical response after 
berculosis treatment were reviewed. Of the 122 episodes, 101 (82.8%) were 
iated with extrapulmonary tuberculosis. The median time from 
encement of treatment to paradoxical deterioration was 60 days. The median 
to onset of central nervous system manifestations (63 days) was longer than 
me to onset of manifestations at other sites (56 days) (P=0.02). Development 
ons in anatomical sites other than those observed at initial presentation 
observed in 31 (25.4%) episodes. A surge in the lymphocyte count, 
mpanied by an exaggerated tuberculin skin reaction, was observed in our 
nts during the paradoxical deterioration, analogous to the findings in 
positive patients. Treatment of the paradoxical response included surgical 
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intervention (60.7%) and administration of steroids (39.3%). The use of steroids 
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<hea ng2>Definition of Paradoxical Response 
ared to be safe in this series, as 95% of the Mycobacterium tuberculosis 
es were susceptible to first-line antituberculosis therapy. 
tion during antituberculosis therapy 
ious disease and respiratory sp
ge has been suggested as a possible explanation for the paradoxical worsening 
berculosis after initiation of treatment [1], a rapid and reliable diagnostic test is 
vailable to substantiate this clinical diagnosis. In fact, a paradoxical response is 
rally defined as the clinical or radiological worsening of pre-existing 
lesions or the development of new lesions in a patient who initially 
oves with antituberculosis therapy. The diagnosis can only be ascertained 
 other differential diagnoses such as secondary community-acquired or 
comial infections, inadequate antituberculosis therapy as a result of drug 
ance, poor compliance, and side effects of antituberculosis therapy, are 
ded. In contrast to the extensive review of paradoxical responses during 
berculosis therapy in HIV-positive patients, there has been no systematic 
sis of this situation in HIV-negative patients. 
is article, we report two HIV-negative patients in whom paradoxical 
ioration occurred during antituberculosis therapy. A surge in the lymphocyte 
t, associated with a strongly positive tuberculin skin test result, was observed 
g the paradoxical response in both patients. A literature review
m of paradoxical response to antituberculosis therapy in HIV-negative 
nts is performed (Medline search, 1966--2001). The anatomical sites of 
vement, the time to development of the paradoxical response, and the issues of 
gement and clinical outcome are also examined. 
ding1>Materials and Methods 
ng2>Patients 
cal data of the two patients were collected prospectively. Clinical specimens 
 collected and handled according to standard protocols [2, 3]. 
di
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logical worsening of pre-existing tuberculous lesions or the development of 
lesions not attributable to the normal course of disease in a patient who initially 
oves with antituberculosis therapy and in whom the onset of paradoxical 
nse is at least 2 weeks after the initiation of treatment. Patients who presented 
progressive tuberculosis without initial clinical improvement, whose 
liance to antituberculosis therapy could not be ascertained, or in whom an 
ative diagnosis was made were excluded. For neurological manifestations, in 
cular, only patients with worsening of preexisting symptoms or a new onset of 
al symptoms or signs such as headache, mental confusion, seizure, cranial 
 palsy, or cortical signs after initial improvement were included, while those 
expected deterioration were excluded from the study. 
ding2>Time to Development of Paradoxical Response 
time to the development of paradoxical response is defined as the interval
nse as defined above. 
ding2>Tuberculin Skin Test Result 
absolute value of induration was measured if available; otherwise, the positive 
gative result was recorded. 
ding2>Literature Review 
nglish literature was searched in the Medline database of the National Library 
edicine (1966--2001). The keywords "tuberculosis", "tuberculous", 
doxical", "worsening", and "deterioration", were used
es
ded in this study if they matched the a
ufficient clinical information was available in order to rule out complications 
than a paradoxical response. The cited bibliographies were also retrieved for 
er analysis, where appropriate. 
ding2>Statistical Analysis 
chi-squared test was used for categorical variables. Continuous variables were 
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tested by the Student's t test. A P value of <0.05 was considered significant. A 
statis
analy
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admi
tical package (SPSS 10.0; SPSS Hong Kong, Hong Kong) was used for all 
ses. 
ng2>Case Reports 
1 was a 56-year-old Chin
rmal liver function and was diag
ving the lungs, right supraclavicular lymph node, and liver. He was treated 
standard antituberculosis therapy, including isoniazid 300 mg q.i.d., 
picin 450 mg q.i.d., pyrazinamide 35 mg/kg, and ethambutol 15 mg/kg, under 
therapy. The baseline Mantoux test was done with 2 tuberculin 
of purified protein derivative, PPD-RT23. No measurable induration was 
ted after 48 h. The lymphocyte count was 570 cells/µl. Subsequently the liver 
y specimen was culture positive for Mycobacterium tuberculosis, which was 
ptible to isoniazid, rifampicin, streptomycin, and ethambutol. Fever, chest 
graph, and liver dysfunction gradually improved after 3 weeks of 
berculosis therapy. 
e months after treatment, the patient developed a painless lump over the right 
apular area of the back. Computer tomography of the thorax revealed a 
×15 cm subcutaneous abscess. Surgical drainage yielded 100 ml of pus that 
sent for microbiological examin
tive for acid-fast bacilli (AFB). A second Mantoux test was performed, and an 
tion of 16 mm was recorded after 48 h. The concomitant lymphocyte count 
elevated, at 2,600 cells/µl. Antituberculosis therapy was continued for a total 
year. The abscess resolved and the patient recovered without further 
lications. He was negative for HIV antibody. 
 2 was a 16-year-old Chinese boy who presented with severe right neck pain 
welling 6 weeks after conventional antituberculosis therapy for 
re-documented tuberculous lymphadenitis of the right anterior and lower 
cal lymph nodes. The Mycobacterium tuberculosis isolate was susceptible to 
azid, rifampicin, streptomycin, and ethambutol. The pretreatment Mantoux 
howed 3 mm of induration, and the lymphocyte count was 1,4
ssion, he had a painful, red, tense, and cystic swelling of 8 cm in diameter over 
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Including the two presented here, a total of 143 episodes of paradoxical response 
was found in the English literature, of which 122 episodes in 104 patients matched 
our d 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 
22, 2
45, 4
range
episodes 
patie
of A
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wher
episo
tuberculos nt of the pleura (12 episodes), lymph nodes (6 
episo sodes), abdomen (3 episodes), and osteoarticular sites 
(2 ep
prese
episo
was 
tuberculosis
Forty
antitu
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gle of the neck, compatible with collar stud abscess. A Mantoux test was 
rmed, and an induration of 23 mm with central necrosis was noted after 48 h. 
lymphocyte count was elevated, at 3,100 cells/µl. A diagnosis of paradoxical 
mmatory response was made. In view of the tense swelling with impending 
formation, surgical drainage was performed. The pus was AFB smear positive, 
FB culture negative. Prednisolone 1 mg/kg was given orally and gradually 
ed off over 12 weeks. The patient completed a 6-month course of 
berculosis therapy and remained well without further complications. 
ding2>Literature Review 
efinition (Table 1) [4, 5, 6, 7, 8, 9, 10, 
3, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 
6, 47, 48, 49, 50, 51, 52, 53, 54]. The male-to-female ratio was 1.2:1. The ages 
d from 4 months to 80 years, with a median of 28 years. Fifty-seven (46.7%) 
occurred in Asian patients. Of these episodes, 27 occurred in Indian 
nts and 18 in Chinese patients, so that these groups together constituted 78.9% 
sian patients. 
itial diagnosis of pulmonary tuberculosis was made in 21 (17.2%) episodes, 
eas extrapulmonary tuberculosis, including disseminated tuberculosis (42 
des), meningitis (26 episodes), intracranial tuberculoma (7 episodes), and 
is with involveme
des), spinal cord (3 epi
isodes) was diagnosed in the remaining 101 (82.8%) episodes (Table 2). The 
nce of Mycobacterium tuberculosis was confirmed by culture in 49 (40.2%) 
des; in 24 of these, smear results for acid-fast bacilli were positive. Diagnosis 
made by histology in 10 episodes in which cultures for Mycobacterium 
 were negative. 
 strains of Mycobacterium tuberculosis were fully susceptible to first-line 
berculosis drugs, while two episodes were caused by strains showing 
ance to pyrazinamide and ethambutol and streptomycin, respectively. The 
tivity patterns of the remaining strains were not mentioned. 
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The clinical symptoms and signs of paradoxical deterioration manifested in the 
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l site of infection in 91 of the 122 (74.6%) episodes, of which 52 occurred in 
entral nervous system and 34 in the respiratory system. A paradoxical response 
rred in an anatomical site other than that of the initial presentation in 31 (25.4%) 
des, of which 8 were initially manifest in the central nervous system and 10 in 
m (Table 2). Overall, the central nervous system was also the 
 common site of involvement in paradoxical response (60/122 episodes), 
wed by the respiratory system (44/122 episodes). 
clinical and radiological manifestations of paradoxical deterioration are 
arized in Table 3. Clinical features of paradoxical deterioration in
us system included headache, mental confusion, focal seizure, cranial nerve 
 cortical signs such as hemiparesis, paraparesis, and hemianesthesia; such 
res resulted from the enlargement or development of intracranial tuberculoma 
ydrocephalus. The most common manifestation in the respiratory system was 
ening or development of pleural effusion, either in the ipsilateral or 
alateral side, while an increase in pulmonary parenchymal infiltration and an 
ase in pleurisy were reported in only two and three episodes, respectively. 
 deterioration occurred in cervical, supraclavicular, and mediastinal 
h nodes as enlargement of pre-existing lesions or development of new cold 
sses. Paradoxical manifestations in skin and soft tissue were reported in eight 
des and were characterized by the development of new lesions such as 
ematous and purpuric papules, painful swelling of the popliteal fossa and thigh 
les, and abscess formation in the abdominal and chest wall. Magnetic 
imaging revealed osteomyelitis of the left humerus and tenosynovitis of 
lexor tendon of the right palm in a patient with bone and tendon involvement. 
 worsening and development of intraabdominal ileocecal masses were also 
ted. Systemic features such as fever were reported in 16 (13.1%) episodes. 
median time to development of paradoxical response was 60 days for all 
des, 63 days for central nervous system involvement, and 56 days for other 
e 1). When the initial site of involvement was analyzed, the median time 
radoxical response was 42 days for pulmonary tuberculosis and 60 days for 
minated tuberculosis (involvement of more than 1 system). Management of 
oxical deterioration included initiation of steroid therapy in 48 (39.3%) 
des. Surgical intervention was employed in 74 (60.7%) episodes, including 
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taneous drainage of pleural effusion, and excision of enlarged lymph nodes 
ubcutaneous abscesses. The regimen of antituberculosis therapy was changed 
 (15.6%) episodes. Conservative management with continuation of the original 
berculosis therapy was adopted in 17 (13.9%) episodes. Ninety-five (77.9%) 
resolved with complete recovery from the paradoxical response. 
ine tuberculin skin tests were reported in 35 (28.7%) episodes, whereas test 
ts during the paradoxical response were only mentioned in 6 episodes (3.3%). 
ersion of tuberculin skin tests from negative to positive was reported in five 
des and the trend of lymphocyte counts in three (Table 4). 
ng1>Discussion 
oxical response is not a rare phenomenon. It is identified in 6--30% of patients
oxical deterioration requires 
e 122 episodes being examined, surgical intervention was employed. 
ification of antituberculosis regimen was initiated in 15%. Twenty-two percent 
episodes were complicated by residual functional deficits. 
uation of the clinical spectrum of paradoxical response showed a high 
ensity for central nervous system involvement, described in 49% of all cases 
ted in the literature [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 
3, 24, 25, 26, 27, 28, 29, 30, 31, 32, 51, 52, 53, 54]. Because the central 
us system is a highly compact and functionally demanding structure confined 
ne, symptomatic neurological deterioration may occur with 
nlargement or appearance of intracranial tuberculomas during paradoxical 
nse. This is in contrary to the situation in patients infected with HIV. In a 
w of 57 episodes of paradoxical response in HIV positive patients, only 2 
) demonstrated new intracranial tuberculomas [57]. 
second most commonly reported manifestation in our series was pleural 
ment, the proportion being similar to that seen in HIV-positive patients [57]. 
ses in which pleural effusion was massive, respiratory function could be 
ely compromised [33, 34, 38, 40, 41]. Symptomatic pleurisy may be 
ienced when an inflammatory reaction in the parietal pleura affects somatic 
ry nerve endings [33, 34]. Increasing pulmonary infiltration during 
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paradoxical response was only reported in two episodes in our series [37, 39]. It 
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be related to the spacious anatomy and good functional reserve of the lungs. 
esions in superficial sites, such as peripheral lymph nodes [6, 23, 42, 43], skin 
oft tissues [44, 45, 46, 47, 48], and bone and tendons [36, 43, 49], the clinical 
toms of paradoxical deterioration are usually obvious. Involvement of lymph 
paradoxical deterioration (4%) in our series was significantly less 
on than that in HIV-positive patients (41%) [57]. The clinical spectrum of 
oxical deterioration may be confounded by functional and anatomical bias. 
over, the spectrum of diseases that were identified on review of the literature 
reflect selection bias, because unusual or severe cases such as those involving 
entral nervous system are more likely to be reported. 
ew lesions in anatomical sites other than those of the initial 
ntation should also heighten the alertness of attending physicians. Late 
rrence of lesions in the central nervous system (8 episodes) and respirat
m (10 episodes) during paradoxical response was not uncommon in our review 
1, 18, 27, 36, 41, 53, 54]. Patients with pulmonary, pleural, miliary, and lymph 
 tuberculosis could develop intracranial tuberculomas between 2 weeks and 3 
ter antituberculosis therapy [9, 11, 18, 27, 53, 54]. Similarly, the 
arance of a pleural effusion could occur after 3--19 weeks of antituberculosis 
py for treatment of tuberculous cervical lymphadenitis, meningitis, abdominal 
ns, and osteoarticular involvement [36, 41]. 
time to onset of paradoxical deterioration occurring in the central nervous 
m appears to be longer when compared with the time to onset at other sites. 
might be explained by the poor drug penetration into the blood-brain barrier of 
flamed meninges after the acute phase of infection. It might take a longer time 
ycobacterial killing and recovery of immune function in the 
eged site [29]. 
oxical response in tuberculosis has been well studied in patients with HIV 
ion. The two markers, lymphocyte count and tuberculin skin test, were found 
elate with paradoxical deterioration after initiation of highly active 
etroviral therapy. Ten of 11 anergic HIV-positive patients with a paradoxical 
ioration demonstrated a strongly delayed hypersensitivity response to the 
culin skin test. The mean 
s after antiretroviral therapy [57]. Our review also demonstrated a conversion 
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linical severity of paradoxical deterioration is dependent on the exactness and 
priateness of immune recovery [58, 59]. An overwhelming and exaggerated 
une recovery may result in excessive immunopathological damage at the tissue 
. 
use of systemic steroids in the management of paradoxical deterioration 
ars to be
lications. Inhaled steroid as adjunctive therapy in tuberculous pyrexia was 
nine HIV-negative patients, in four of whom defervescence of fever was 
ved between 2 and 5 days [60]. Oxpentifylline was added in a 44-year-old 
positive patient for paradoxical enlargement of the mediastinal lymph node 
orsening of pulmonary infiltrates that occurred 5 months after of initiation of 
berculosis therapy [61]. In an experimental model, a combination of 
omide plus antibiotics was shown to protect rabbits from death due to 
is meningitis via the inhibition of tumor necrosis factor [62], indicating 
halidomide might be a potential agent in the treatment of paradoxical 
ioration in future. 
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Table 1. s 
thera
 PR within CNS, PR in other P value 
Male: female ratio 1.2: 1 
Median age in years 
(range) 
26 (0.3--75
No. in whom baseline 
TST 
20 (33.3%) 
Medi
onset ge) 
4--27 02) 
No. who recei d steroid 
thera
38 (63.3%) 10 (16.1%) P<0.001 
No. w
surgi
35%) 53 (85.5%) P<0.001 
No. w
PR 
68.3%) 54 (87.1%) P=0.001 
CNS, central b  
aOthers sit (n=42), pulmonary system (n=2), skin and soft tissue 
(n=8), e and ten d abdom
bInclu
 
unorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol 
t Dis 20:402--406 
ew WW, Chau CH, Lee J, Le
ctive management in tuberculous pyrexia? Drugs Exp Clin Res 25:179--184 
hn M, French MA (1998) Exacerbation of the inflammatory response to 
bacterium tuberculosis after antiretroviral therapy. Med J Aust 169:473--474 
senova L, Sokol K, Freedman VH, Kaplan G (1998) A combination of 
omide plus antibiotics protects rabbits from mycobacterial 
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 Summary of cases of paradoxical response (PR) after antituberculosi
py reported in the English-language literature 
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cord (n=60) 
systemsa 
(n=62b) 
1.2:1 
) 32 (14--80) 
15 (24.2%) 
 
P=0.01 
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was performed 
an no. of days to 
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es included pleura 
erculin skin test
 lymph node (n=5), bon
ding our two patients 
don (n=3), an en (n=2) 
 15 
Table 2. Initial site(s) of involvement in 122 patients presenting with paradoxical 
respo
Site
respo
ent No. of 
 
CNS CNS (n=52)  
   meninges 23 
   meninges 3 
   meninges 5 
   meninges 5 
   meninges
   meninges
   meninges pl
   IT plus lu
   IT plus pl 1 
   IT plus sp 2 
   spinal cor idymis 1 
   spinal cor 1 
 Other sites 
   lungs 2 
   miliary 
   lungs & m
Respi tory system (n=44) Respiratory  
   lungs 19 
   left pleura 6 
   right pleu 4 
   bilateral p 2 
 s
   lungs plus  1 
 Other sites  
   cervical lym 4 
   abdomen 2 
   meninges 1 
   spinal cor 1 
   miliary 1 
nse during antituberculosis therapy 
s of paradoxical Site(s) of initial involvem
nse 
 (n=60) 
episodes
 plus lungs 
 plus miliary 
plus lungs & miliary 
 plus lymph node 1 
 plus bone 1 
us IT 7 
ngs 2 
eura 
inal cord  
d plus testes & epid
d plus lungs & miliary 
(n=8)  
4 
iliary 2 
ra  system (n=34) 
ra 
leura 
  lungs plu  pleura 2 
 abdomen
(n=10) 
ph node 
d 
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Sites of paradoxical 
response 
Site(s) of initial involvement No. of 
episodes 
   bone & joint 1 
Skin and soft tissue (n=8) Miliary 8 
Lym ly 2 
 mph node plus 1 
 ther site: 2 
Bone and tendon (n=3) Bone & joi
 Miliary 1 
 s & ly 1 
Abdo en (n=2) Abdomen 1 
 Miliary 1 
CNS, central nervous system; IT, intracra
 
Table 3. Clinical and radiological presen 22 episodes of paradoxical 
respo
Clinical and radiological presentation of 
paradoxical response by site 
No. of 
episodes 
CN
  He
  Men
  Seiz 16 
  Foc gnsa 36 
  Tub 46 
  Hydroceph 9 
Respi  
  Pleu 3 
  Incr 2 
  Wo n 8 
  Develop n 30 
  Con sion 4 
Skin  
  Dev  lesion(s) 8 
Lym
ph nodes (n=5) Original mph node 
Ly
O
meninges 
meninges 
nt 1 
Lung mph node 
m
nial tuberculoma 
tations in 1
nse during antituberculosis therapy 
S (n=60)  
adache 12 
tal confusion 8 
ure 
al neurological si
erculoma(s)b 
alus 
ratory system (n=44) 
risy 
easing pulmonary infiltration 
rsening of pleural effusio
ment of new pleural effusio
tralateral pleural effu
and soft tissue (n=8) 
elopment of new
ph node(s) (n=5)  
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Clinical and radiological presentation of 
paradoxical response by site 
No. of 
episodes 
  Inflammation of pre-existing lymph 
node(
2 
  Dev f new lymph node(s) 3 
Bone an
  Dev
Abdo  
  Infl
  Dev on 1 
CNS, 
aCran nction (n=17), sensory dysfunction 
(n=7), and cerebella
bIntracrania medullary tuberculoma (n=2) 
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elopment o
d tendon (n=3)  
elopment of new lesion(s) 3 
men (n=2) 
ammation of pre-existing lesion  1 
elopment of new lesi
central nervous system 
ial nerve(s) palsy (n=7), motor dysfu
r signs (n=5) 
l tuberculoma(s) (n=44), and intra
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Table 4. Patients with sequential tuberculin skin tests before and after paradoxical response 
Refere Sex/age Initial site(s) Presentation of PR Time to onset Baseline B
n o of PR 
nt 
s/µl) 
aseline TST Lymphocyte 
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TST result at 
 
Treatment
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meningitis 
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M/16 cervical 
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surgical dr
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(0 m mm) 
a
NM, not mentioned; PR, paradoxical resp uberculin skin test 
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D4+ cell count 
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